Cardiomyopathy natural history, complications and prognosis

Jump to navigation Jump to search

Cardiomyopathy Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cardiomyopathy from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Guidelines

2023 ESC Guideline Recommendations

2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy

Case Studies

Case #1

Cardiomyopathy natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cardiomyopathy natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cardiomyopathy natural history, complications and prognosis

CDC on Cardiomyopathy natural history, complications and prognosis

Cardiomyopathy natural history, complications and prognosis in the news

Blogs on Cardiomyopathy natural history, complications and prognosis

Directions to Hospitals Treating Cardiomyopathy

Risk calculators and risk factors for Cardiomyopathy natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Overview

Cardiomyopathy will continue to progressively worsen, unless intervened on. Complications and sequelae of cardiomyopathy include heart failure, arrythmia, thromboembolic disease, and sudden cardiac death. Prognosis of patients depends on the etiology of the cardiomyopathy and the initiation of management, whether medical, surgical and device management. Patients with cardiomyopathy are usually treated with medical treatment similar to heart failure patients, although some patients do not respond well to medications and continue to have worsening heart function, which may require heart transplant eventually. Those patients at high risk for fatal arrhythmias and sudden cardiac death should receive device therapy with implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy (CRT).

Complications

Cardiomyopathy gets worse unless treated. The most likely complications are;

References

Template:Sisakian H. Cardiomyopathies: Evolution of pathogenesis concepts and potential for new therapies. World J Cardiol. 2014;6(6):478-94Template:WH Template:WS Template:Al-Khatib SM, Fonarow GC, Joglar JA, et al. Primary Prevention Implantable Cardioverter Defibrillators in Patients With Nonischemic Cardiomyopathy: A Meta-analysis. JAMA Cardiol. 2017;2(6):685-688.

Template:Wexler RK, Elton T, Pleister A, Feldman D. Cardiomyopathy: an overview. Am Fam Physician. 2009;79(9):778-84.